MacroGenics, Inc. (MGNX)
Latest news, insights and market data
Market Data
$4.17
$0.08 (+1.96%)
Previous Close: $4.09
52-Week Range
82% from low
$0.00$5.08
AI Insights
No news
Updated about 21 hours ago
Latest News
| Title | Published |
|---|---|
B. Riley Securities Maintains Buy on Macrogenics, Raises Price Target to $11 B. Riley Securities analyst Mayank Mamtani maintains Macrogenics (NASDAQ:MGNX) with a Buy and raises the price target from $9 to $11. | 3 days ago |
B. Riley Raises Price Target on MacroGenics to $11 From $9, Keeps Buy Rating B. Riley Raises Price Target on MacroGenics to $11 From $9, Keeps Buy Rating | 3 days ago |
Can MacroGenics (MGNX) Turn Gilead Sciences (GILD)’s $10M Milestone Into a Major Pipeline Catalyst? Can MacroGenics (MGNX) Turn Gilead Sciences (GILD)’s $10M Milestone Into a Major Pipeline Catalyst? | 5 days ago |
MacroGenics (MGNX) Reports Q2 Loss, Lags Revenue Estimates MacroGenics (MGNX) Reports Q2 Loss, Lags Revenue Estimates | 6 days ago |
MacroGenics: Q2 Earnings Snapshot MacroGenics: Q2 Earnings Snapshot | 6 days ago |
MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position | 6 days ago |
Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates | 8 days ago |
B. Riley Securities Maintains Buy on Macrogenics, Raises Price Target to $11
B. Riley Securities analyst Mayank Mamtani maintains Macrogenics (NASDAQ:MGNX) with a Buy and raises the price target from $9 to $11.
3 days ago
B. Riley Raises Price Target on MacroGenics to $11 From $9, Keeps Buy Rating
B. Riley Raises Price Target on MacroGenics to $11 From $9, Keeps Buy Rating
3 days ago
Can MacroGenics (MGNX) Turn Gilead Sciences (GILD)’s $10M Milestone Into a Major Pipeline Catalyst?
Can MacroGenics (MGNX) Turn Gilead Sciences (GILD)’s $10M Milestone Into a Major Pipeline Catalyst?
5 days ago
MacroGenics (MGNX) Reports Q2 Loss, Lags Revenue Estimates
MacroGenics (MGNX) Reports Q2 Loss, Lags Revenue Estimates
6 days ago
MacroGenics: Q2 Earnings Snapshot
MacroGenics: Q2 Earnings Snapshot
6 days ago
MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position
MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position
6 days ago
Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates
Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates
8 days ago